327 related articles for article (PubMed ID: 10969790)
1. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong G; Braun RD; Dewhirst MW
Cancer Res; 2000 Aug; 60(16):4440-5. PubMed ID: 10969790
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature.
Kong G; Braun RD; Dewhirst MW
Cancer Res; 2001 Apr; 61(7):3027-32. PubMed ID: 11306483
[TBL] [Abstract][Full Text] [Related]
3. Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia.
Li L; ten Hagen TL; Bolkestein M; Gasselhuber A; Yatvin J; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Apr; 167(2):130-7. PubMed ID: 23391444
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
5. Study of non-uniform nanoparticle liposome extravasation in tumour.
Liu P; Zhang A; Xu Y; Xu LX
Int J Hyperthermia; 2005 May; 21(3):259-70. PubMed ID: 16019852
[TBL] [Abstract][Full Text] [Related]
6. A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation.
Kleiter MM; Yu D; Mohammadian LA; Niehaus N; Spasojevic I; Sanders L; Viglianti BL; Yarmolenko PS; Hauck M; Petry NA; Wong TZ; Dewhirst MW; Thrall DE
Clin Cancer Res; 2006 Nov; 12(22):6800-7. PubMed ID: 17121901
[TBL] [Abstract][Full Text] [Related]
7. Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate.
Djanashvili K; ten Hagen TL; Blangé R; Schipper D; Peters JA; Koning GA
Bioorg Med Chem; 2011 Feb; 19(3):1123-30. PubMed ID: 20624680
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.
Chelvi TP; Jain SK; Ralhan R
Oncol Res; 1995; 7(7-8):393-8. PubMed ID: 8747602
[TBL] [Abstract][Full Text] [Related]
9. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
10. Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice.
Mirahmadi N; Babaei MH; Vali AM; Dadashzadeh S
Int J Pharm; 2010 Jan; 383(1-2):7-13. PubMed ID: 19729056
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermia mediated liposomal drug delivery.
Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
[TBL] [Abstract][Full Text] [Related]
12. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
Devalapally H; Shenoy D; Little S; Langer R; Amiji M
Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
[TBL] [Abstract][Full Text] [Related]
13. Tumor priming enhances delivery and efficacy of nanomedicines.
Lu D; Wientjes MG; Lu Z; Au JL
J Pharmacol Exp Ther; 2007 Jul; 322(1):80-8. PubMed ID: 17420296
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model.
Wang SX; Bao A; Phillips WT; Goins B; Herrera SJ; Santoyo C; Miller FR; Otto RA
Int J Pharm; 2009 May; 373(1-2):156-64. PubMed ID: 19429301
[TBL] [Abstract][Full Text] [Related]
15. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.
Needham D; Anyarambhatla G; Kong G; Dewhirst MW
Cancer Res; 2000 Mar; 60(5):1197-201. PubMed ID: 10728674
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor.
van Bree C; Krooshoop JJ; Rietbroek RC; Kipp JB; Bakker PJ
Cancer Res; 1996 Feb; 56(3):563-8. PubMed ID: 8564972
[TBL] [Abstract][Full Text] [Related]
17. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia.
Meyer DE; Kong GA; Dewhirst MW; Zalutsky MR; Chilkoti A
Cancer Res; 2001 Feb; 61(4):1548-54. PubMed ID: 11245464
[TBL] [Abstract][Full Text] [Related]
18. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.
Yuan F; Leunig M; Huang SK; Berk DA; Papahadjopoulos D; Jain RK
Cancer Res; 1994 Jul; 54(13):3352-6. PubMed ID: 8012948
[TBL] [Abstract][Full Text] [Related]
19. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.
Maruyama K
Adv Drug Deliv Rev; 2011 Mar; 63(3):161-9. PubMed ID: 20869415
[TBL] [Abstract][Full Text] [Related]
20. Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity.
Shan S; Flowers C; Peltz CD; Sweet H; Maurer N; Kwon EJ; Krol A; Yuan F; Dewhirst MW
Cancer Chemother Pharmacol; 2006 Aug; 58(2):245-55. PubMed ID: 16341532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
